NEW YORK (GenomeWeb) – Oncologist group Valley Medical Oncology Consultants and Caris Life Sciences will establish a clinical molecular profiling program to serve cancer patients in the San Francisco Bay Area, they announced today.
The collaboration will use Caris Molecular Intelligence, a tumor profiling service to identify target therapies for patients based on their unique cancer biology. The service integrates molecular data generated from a patient's tumor into a report that includes biomarkers that are associated with therapies and/or available clinical trials.
The deal includes clinical support, patient and physician education, molecular tumor boards, and system integration, and it creates a pathway for potential future collaborative research, VMOC and Caris said.
Financial and other terms of the deal were not disclosed.